PET/CT and occult primary tumors

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 7, Issue 3, 2009, Pages 239-244

  Podoloff, Donald A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer of unknown origin; PET CT; Unknown primary and PET CT; Unknown primary site

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING;

EID: 63449103165     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2009.0019     Document Type: Article

References (25)

1. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003;39:1990-2005.
2. Golder WA. Lymph node diagnosis in oncologic imaging: a dilemma still waiting to be solved. Onkologie 2004;27:194-199.
3. Donta TS, Smoker WR. Head and neck cancer: carcinoma of unknown primary. Top Magn Reson Imaging 2007;18:281-292.
4. Basu S, Alavi A. FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies. Eur J Nucl Med Mol Imaging 2007;34:427-428.
5. Guntinas-Lichius O, Peter Klussmann J, Dinh S, et al. Diagnostic work-up and outcome of cervical metastases from an unknown primary. Acta Otolaryngol 2006;126:536-544.
6. Gutzeit A, Antoch G, Kuhl H, et al. Unknown primary tumors: detection with dual-modality PET/CT - initial experience. Radiology 2005;234:227-234.
7. Kolesnikov-Gauthier H, Levy E, Merlet P, et al. FDG PET in patients with cancer of an unknown primary. Nucl Med Commun 2005;26:1059-1066.
8. Mevio E, Gorini E, Sbrocca M, et al. The role of positron emission tomography (PET) in the management of cervical lymph nodes metastases from an unknown primary tumor. Acta Otorhinolaryngologica. Italica 2004;24:342-347.
9. Miller FR, Hussey D, Beeram M, et al. Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg 2005;131:626-629.
10. Nanni C, Rubello D, Castellucci P et al. Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumor: preliminary results in 21 patients. Eur J Nucl Med Mol Imaging 2005;32:589-592.
11. Paul SA, Stoeckli SJ, von Schulthess GK, et al. FDG PET and PET/CT for the detection of the primary tumor in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary. Eur Arch Otorhinolaryngol 2007;264:189-195.
12. Scott CL, Kudaba I, Stewart JM, et al. The utility of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin. Mol Imaging Biol 2005;7:236-243.
13. Stoeckli SJ, Mosna-Firlejczyk K, Goerres GW. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography. Eur J Nucl Med Mol Imaging 2003;30:411-416.
14. Wong WL, Saunders M. The impact of FDG PET on the management of occult primary head and neck tumours. Clin Oncol (R Coll Radiol) 2003;15:461-466.
15. Delgado-Bolton RC, Fernandez-Perez C, Gonzalez-Mate A, Carreras JL. Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med 2003;44:1301-1314.
16. Seve P, Billotey C, Broussolle C, et al. The role of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site. Cancer 2007;109:292-299.
17. Alberini JL, Belhocine T, Hustinx R, et al. Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumors (CUP syndrome). Nucl Med Commun 2003;24:1081-1086.
18. Fencl P, Belohlavek O, Skopalova M, et al. Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown primary. Eur J Nucl Med Mol Imaging 2007;34:1783-1792.
19. Freudenberg LS, Rosenbaum-Krumme SJ, Bockisch A, et al. Cancer of unknown primary. Recent Results Cancer Res 2008;170:193-202.
20. Garin E, Prigent-Lejeune F, Lesimple T, et al. Impact of PET-FDG in the diagnosis and therapeutic care of patients presenting with metastases of unknown primary. Cancer Invest 2007;25:232-239.
21. Johansen J, Buus S, Loft A, et al. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck 2008;30:471-478.
22. Joshi U, van der Hoeven JJ, Comans EF, et al. In search of an unknown primary tumor presenting with extracervical metastases: the diagnostic performance of FDG-PET. Br J Radiol 2004;77:1000-1006.
23. Miller FR, Karnad AB, Eng T, et al. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 2008;30:28-34.
24. Stoeckli SJ, Mosna-Firlejczyk K, Goerres GW, et al. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography. Eur J Nucl Med Mol Imaging 2003;30:411-416.
25. Wartski M, Le Stanc E, Gontier E, et al. In search of an unknown primary tumor presenting with cervical metastases: performance of hybrid FDG-PET-CT. Nucl Med Commun 2007;28:365-371.